Association between hand-grip strength and risk of stroke among Mongolian adults: Results from a population-based study


  • Indra Altankhuyag Department of Endocrinology, Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia.
  • Agiimaa Byambaa Department of Endocrinology, Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia.
  • Anujin Tuvshinjargal Department of Endocrinology, Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia.
  • Anar Bayarmunkh Department of Endocrinology, Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia.
  • Tsolmon Jadamba TimeLine Research Center, Ulaanbaatar 14240, Mongolia.
  • Byambasuren Dagvajantsan Department of Neurology, Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia.
  • Oyuntugs Byambasukh Department of Endocrinology, Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia.



hand grip strength, stroke, sarcopenia, sarcopenic obesity, hypertension


Mongolia ranks third in the world in stroke-related deaths. Loss of skeletal muscle mass and function, known as sarcopenia, is associated with a higher risk of various metabolic disorders such as stroke. Thus, screening of sarcopenia is important. Hand-grip strength (HGS) can be used to predict sarcopenia in the short term. In this cross-sectional study, we used data (n=1180, mean age of 39.2 ± 15.2 and 33.2% males) from the Mon-Timeline cohort study, a multidisciplinary, prospective, population-based cohort study in Mongolia. A digital grip strength dynamometer (TKK 5401 GRIP D; Takei, Japan) was used to measure HGS. We performed binary logistic regression analysis between HGS and stroke risk. Suspected sarcopenia was defined when HGS is less than the 25th percentile of HGS. In this study, 3.3% of all participants had a stroke. The incidence of stroke was significantly higher (5.2% and 1.9%) in people with suspected sarcopenia. According to body composition, the incidence of stroke was more frequent in sarcopenic obese people: 1.3%, 2.4%, 2.8% and 6.2% in normal (non-obese and non-sarcopenic), sarcopenic (non-obese), obese (non-sarcopenic) and sarcopenic obese groups, respectively. In regression analysis, the OR (95% CI) was 2.84 (1.44; 5.59) for sarcopenic compared with non-sarcopenic. The adjustments for age, gender, education, body mass index, waist circumference and hypertensive status attenuated the associations, but lower HGS remained significantly associated with a higher risk of stroke. In conclusion, lower HGS was significantly associated with a higher risk of stroke independent of adiposity and hypertensive status in Mongolian adults.


Al Snih, S., Markides, K., Ottenbacher, K., & Raji, M. (2004). Hand grip strength and incident ADL disability in elderly Mexican Americans over a seven-year period. Aging Clinical and Experimental Research, 16(6), 481–486.

Armstrong, T., & Bull, F. (2006). Development of the World Health Organization Global Physical Activity Questionnaire (GPAQ). Journal of Public Health, 14(2), 66–70.

Bai, T., Fang, F., Li, F., Ren, Y., Hu, J., & Cao, J. (2020). Sarcopenia is associated with hypertension in older adults: a systematic review and meta-analysis. BMC Geriatrics 2020 20:1, 20(1), 1–9.

Baumgartner, R. (2000). Body composition in healthy aging. Annals of the New York Academy of Sciences, 904, 437–448.

Celis-Morales, C. A., Welsh, P., Lyall, D. M., Steell, L., Petermann, F., Anderson, J., Iliodromiti, S., Sillars, A., Graham, N., Mackay, D. F., Pell, J. P., Gill, J. M. R., Sattar, N., & Gray, S. R. (2018). Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. BMJ, 361, k1651.

Center for health development, M. (2020). Health indicators.

Chung, J.-Y., Kang, H.-T., Lee, D.-C., Lee, H.-R., & Lee, Y.-J. (2013). Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Archives of Gerontology and Geriatrics, 56(1), 270–278.

Field, A., Coakley, E., Must, A., Spadano, J., Laird, N., Dietz, W., Rimm, E., & Colditz, G. (2001). Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Archives of Internal Medicine, 161(13), 1581–1586.

Frankenfield, D., Rowe, W., Cooney, R., Smith, J., & Becker, D. (2001). Limits of body mass index to detect obesity and predict body composition. Nutrition (Burbank, Los Angeles County, Calif.), 17(1), 26–30.

Gregor, M., & Hotamisligil, G. (2011). Inflammatory mechanisms in obesity. Annual Review of Immunology, 29, 415–445.

Houtkooper, L., Lohman, T., Going, S., & Howell, W. (1996). Why bioelectrical impedance analysis should be used for estimating adiposity. The American Journal of Clinical Nutrition, 64(3 Suppl).

Kim, T., Park, M., Lim, K., Choi, H., Yang, S., Yoo, H., Kang, H., Song, W., Choi, H., Baik, S., Choi, D., & Choi, K. (2013). Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study. Clinical Endocrinology, 78(4), 525–532.

Lera, L., Albala, C., Leyton, B., Márquez, C., Angel, B., Saguez, R., & Sánchez, H. (2018). Reference values of hand-grip dynamometry and the relationship between low strength and mortality in older Chileans. Clinical Interventions in Aging, 13, 317.

Lindsay, M., Norrving, B., Sacco, R., Brainin, M., Hacke, W., Martins, S., Pandian, J., & V, F. (2019). World Stroke Organization (WSO): Global Stroke Fact Sheet 2019. International Journal of Stroke : Official Journal of the International Stroke Society, 14(8), 806–817.

Metter, E., Talbot, L., Schrager, M., & Conwit, R. (2002). Skeletal muscle strength as a predictor of all-cause mortality in healthy men. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 57(10), B359–B365.

Narayan, K., Boyle, J., Thompson, T., Gregg, E., & Williamson, D. (2007). Effect of BMI on lifetime risk for diabetes in the US Diabetes Care, 30(6), 1562–1566.

Oterdoom, L., Gansevoort, R., Schouten, J., de Jong, P., Gans, R., & Bakker, S. (2009). Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis, 207(2), 534–540.

Roh, E., & Choi, K. (2020). Health Consequences of Sarcopenic Obesity: A Narrative Review. Frontiers in Endocrinology, 11, 332.

Stephen, W., & Janssen, I. (2009). Sarcopenic-obesity and cardiovascular disease risk in the elderly. The Journal of Nutrition, Health & Aging, 13(5), 460–466.

Suvd, J., Gerel, B., Otgooloi, H., Purevsuren, D., Zolzaya, H., Roglic, G., & King, H. (2002). Glucose intolerance and associated factors in Mongolia: results of a national survey. Diabetic Medicine : A Journal of the British Diabetic Association, 19(6), 502–508.

Wang, J., Thornton, J., Bari, S., Williamson, B., Gallagher, D., Heymsfield, S., Horlick, M., Kotler, D., Laferrère, B., Mayer, L., Pi-Sunyer, F., & Pierson, R. (2003). Comparisons of waist circumferences measured at 4 sites. The American Journal of Clinical Nutrition, 77(2), 379–384.

Wannamethee, S., & Atkins, J. (2015). Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. The Proceedings of the Nutrition Society, 74(4), 405–412.

Wannamethee, S., Shaper, A., Lennon, L., & Whincup, P. (2007). Decreased muscle mass and increased central adiposity are independently related to mortality in older men. The American Journal of Clinical Nutrition, 86(5), 1339–1346.

Willey, J., Moon, Y., Kahn, E., Rodriguez, C., Rundek, T., Cheung, K., Sacco, R., & Elkind, M. (2014). Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study. Journal of the American Heart Association, 3(5), e001106.

World Health Organization. (2008). Mongolian STEPS survey on the prevalence of noncommunicable disease risk factors 2006.

World Health Organization. (2020). Mongolia completes its 4th round of STEPS survey on the prevalence of NCD risk factors.

World Life Expectancy. (2020). Stroke in Mongolia.

Xia, M., Chen, L., Wu, L., Ma, H., Li, X., Li, Q., Aleteng, Q., Hu, Y., He, W., Gao, J., Lin, H., & Gao, X. (2021). Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study. Clinical Nutrition, 40(2), 571–580.

Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008). Sarcopenic obesity: a new category of obesity in the elderly. Nutrition, Metabolism, and Cardiovascular Diseases, 18(5), 388–395.




How to Cite

Altankhuyag, I., Byambaa, A., Tuvshinjargal, A., Bayarmunkh, A., Jadamba, T., Dagvajantsan, B. and Byambasukh, O. (2021) “Association between hand-grip strength and risk of stroke among Mongolian adults: Results from a population-based study”, Neuroscience Research Notes, 4(3Suppl), pp. 8–16. doi: 10.31117/neuroscirn.v4i3Suppl.97.